全文获取类型
收费全文 | 151篇 |
免费 | 13篇 |
国内免费 | 30篇 |
专业分类
儿科学 | 11篇 |
基础医学 | 16篇 |
临床医学 | 15篇 |
内科学 | 27篇 |
神经病学 | 12篇 |
特种医学 | 59篇 |
外科学 | 11篇 |
综合类 | 14篇 |
预防医学 | 7篇 |
眼科学 | 1篇 |
药学 | 13篇 |
肿瘤学 | 8篇 |
出版年
2023年 | 1篇 |
2018年 | 4篇 |
2016年 | 2篇 |
2015年 | 3篇 |
2014年 | 1篇 |
2013年 | 2篇 |
2011年 | 1篇 |
2010年 | 2篇 |
2009年 | 5篇 |
2008年 | 3篇 |
2007年 | 12篇 |
2006年 | 2篇 |
2005年 | 10篇 |
2003年 | 2篇 |
2002年 | 1篇 |
2001年 | 8篇 |
2000年 | 7篇 |
1999年 | 3篇 |
1998年 | 12篇 |
1997年 | 8篇 |
1996年 | 6篇 |
1995年 | 9篇 |
1994年 | 13篇 |
1993年 | 6篇 |
1992年 | 1篇 |
1991年 | 7篇 |
1990年 | 3篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 7篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1975年 | 4篇 |
1969年 | 1篇 |
排序方式: 共有194条查询结果,搜索用时 359 毫秒
31.
Epstein DM; Stephenson LW; Gefter WB; van der Voorde F; Aronchik JM; Miller WT 《Radiology》1986,161(2):423-427
Practicing thoracic surgeons were randomly surveyed to evaluate how computed tomography (CT) has influenced the preoperative evaluation of bronchogenic carcinoma. Thirty-six percent of the 529 respondents routinely requested CT and 62% did so selectively. Approximately 40% indicated that CT provided useful information in most cases. Nearly all surgeons (98.7%) do not rely on the identification of enlarged lymph nodes with CT to spare the patient surgical staging; however, 77.5% are influenced by CT results in their staging procedures. Fifty-seven percent reported that a negative CT study eliminates surgical staging entirely unless the patient has a "coin lesion," in which case 75% are willing to proceed directly to thoracotomy. For surgeons who use CT selectively, an abnormal mediastinal contour on the radiograph was the most frequent radiologic abnormality to prompt CT (85%). Thirty-seven percent are influenced by tumor histology in their decision to request CT. There was little difference in the pattern of CT use between university and community hospital surgeons. 相似文献
32.
33.
34.
Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients 总被引:3,自引:0,他引:3
DE Hogge ; M McConnell ; C Jacobson ; HJ Sutherland ; WB Benny ; BG Massing 《Transfusion》1995,35(8):645-652
BACKGROUND: The purposes of this study were to determine the overall incidence of platelet refractoriness and alloimmunization among multiply transfused children on a medical oncology and bone marrow transplant service and to evaluate the effect of routine white cell reduction in blood components on that incidence. STUDY DESIGN AND METHODS : The platelet transfusion records of 128 consecutive children admitted to the hospital and requiring blood component support for the treatment of disease were evaluated retrospectively. Mean corrected count increments (CCIs) for each patient were calculated for all random- donor platelet transfusions given within 7 days of the routine weekly testings of the patient's serum for lymphocytotoxic antibodies (LCTAbs). Mean CCIs for HLA-matched platelet transfusions were calculated separately for the patients receiving them. RESULTS : Thirty- one patients (24%) had or developed persistently positive LCTAbs (patient's serum reacted with > or = 3/10 panel lymphocytes); 22 (71%) of these patients had a mean CCI < 7.5 to random-donor platelet transfusions. In contrast, of the 97 patients with negative or transiently positive LCTAbs, only 25 (26%) had a mean CCI < 7.5. The overall incidence of platelet refractoriness (CCI < 7.5) was 37 percent. Patients with acute myelogenous leukemia had a significantly (p < 0.01) reduced incidence (17%) of low CCIs, with or without positive LCTAbs, as compared to patients with other malignant or nonmalignant disorders (41%). No difference in the incidence of LCTAbs or low CCIs was seen in patients undergoing allogeneic or autologous bone marrow transplant or receiving drug therapy only. Among the 24 patients who received HLA-matched platelets, only those with positive LCTAbs showed a significant improvement in CCIs over that achieved with random-donor platelet transfusions. Routine white cell reduction in red cell and platelet components with third-generation white cell filters was performed prior to transfusion in 73 of the patients. There was no significant difference between the incidence of LCTAbs and/or low CCIs in this group and that in the 55 children receiving unfiltered transfusions. CONCLUSION : Alloimmunization and platelet refractoriness occur in pediatric oncology and bone marrow transplant patients, but the incidence-particularly in children with acute myelogenous leukemia- -appears to be low. The detection of LCTAbs predicts a poor response to random-donor platelet transfusion, but most such patients show improved CCIs with HLA-matched platelets. Routine use of white cell-reduction filters has thus far failed to eliminate alloimmunization in children requiring prolonged blood component support. 相似文献
35.
Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation 总被引:3,自引:0,他引:3
Kadakia MP; Rybka WB; Stewart JA; Patton JL; Stamey FR; Elsawy M; Pellett PE; Armstrong JA 《Blood》1996,87(12):5341-5354
Human herpesvirus 6 activity (HHV-6) was studied in 15 allogeneic and 11 autologous marrow transplantation patients. After transplantation, HHV-6 was isolated from the peripheral blood mononuclear cells of 12 of 26 patients (6 allogeneic and 6 autologous). All isolates were variant B. Eleven of 26 and 12 of 19 patients showed salivary shedding of HHV-6 DNA before and after transplantation, respectively. The antibody titer increased in 7 of 26 patients. Thus, 23 of 26 patients showed evidence of active HHV-6 infection either by virus isolation, salivary shedding, or increases in antibody titers. The fraction of saliva specimens positive in 19 patients was negatively associated with their antibody titers (P= .005). The proportion of cultures positive increased after transplantation (P = .007). Sinusitis was associated with HHV-6 isolation in autologous recipients (P= .002). In allogeneic patients, active human cytomegalovirus infection was associated with HHV-6 isolation (P = .04). No association was observed between HHV-6 infection and GVHD, pneumonia, delay in engraftment, or marrow suppression. Of the 120 clinical events analyzed in 26 patients, HHV-6 was defined as a probable cause of 16 events in 9 patients based on the propinquity of HHV-6 activity and the clinical event plus the absence of other identified causes of the event. 相似文献
36.
Acute thrombotic and hemorrhagic manifestations of thrombocytosis associated with myeloproliferative disorders may be life threatening. Conventional therapy with radioisotopes and/or cytotoxic drugs may require weeks for effective control of platelet counts. In five patients, plateletpheresis by discontinuous-flow (Haemonetics) or continuous-flow (Aminco Celltrifuge) centrifugation was used as a means of reducing platelet counts acutely. With each procedure, approximately 2-9 X 10(12) platelets were removed, resulting in decrements in platelet counts and relief of symptoms. Plateletpheresis is a useful and safe acute means of controlling platelet counts in myeloproliferative disorders. 相似文献
37.
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma 总被引:4,自引:0,他引:4
Chesler L Goldenberg DD Seales IT Satchi-Fainaro R Grimmer M Collins R Struett C Nguyen KN Kim G Tihan T Bao Y Brekken RA Bergers G Folkman J Weiss WA 《Cancer research》2007,67(19):9435-9442
Targeted expression of MYCN to the neural crest [under control of the rat tyrosine hydroxylase (TH) promoter] causes neuroblastoma in transgenic mice (TH-MYCN) and is a well-established model for this disease. Because high levels of MYCN are associated with enhanced tumor angiogenesis and poor clinical outcome in neuroblastoma, we serially characterized malignant progression, angiogenesis, and sensitivity to angiogenic blockade in tumors from these animals. Tumor cells were proliferative, secreted high levels of the angiogenic ligand vascular endothelial growth factor (VEGF), and recruited a complex vasculature expressing the angiogenic markers VEGF-R2, alpha-SMA, and matrix metalloproteinases MMP-2 and MMP-9, all of which are also expressed in human disease. Treatment of established murine tumors with the angiogenesis inhibitor TNP-470 caused near-complete ablation, with reduced proliferation, enhanced apoptosis, and vasculature disruption. Because TNP-470 has been associated with neurotoxicity, we tested the recently described water-soluble HPMA copolymer-TNP-470 conjugate (caplostatin), which showed comparable efficacy and was well tolerated without weight loss or neurotoxicity as measured by rotarod testing. This study highlights the importance of angiogenesis inhibition in a spontaneous murine tumor with native tumor-microenvironment interactions, validates the use of mice transgenic for TH-MYCN as a model for therapy in this common pediatric tumor, and supports further clinical development of caplostatin as an antiangiogenic therapy in childhood neuroblastoma. 相似文献
38.
39.
109 children who survived surgical treatment for isolated pulmonary valve stenosis were followed for up to 17 years. In all the postoperative status was assessed as satisfactory. Cardiac catheterization repeated in 43 gave a resting valve gradient below 40 mmHg. The 22 children whose pulmonary valves had been excised were as healthy as the 87 who had undergone pulmonary valvotomy. Consideration was given to the desirable length of postoperative review. Except for the few children with symptoms before operation, a postoperative increase in exercise tolerance was not a feature. 相似文献
40.
Barthelman M; Bair WB rd; Stickland KK; Chen W; Timmermann BN; Valcic S; Dong Z; Bowden GT 《Carcinogenesis》1998,19(12):2201-2204
Green tea polyphenols have been shown to inhibit cancer in a variety of
tumor models, including ultraviolet B (UVB)-induced non-melanoma skin
cancer. In green tea extracts, the major dry mass constituent is the family
of catechins, of which (-)-epigallocatechin-(3)-gallate (EGCG) is
considered to be important for the chemopreventive activity. EGCG has been
shown to have antioxidant properties, but there has been little progress
toward identifying the specific targets and mechanisms of its action. Using
cultured human keratinocytes, we show that UVB- induced AP-1 activity is
inhibited by EGCG in a dose range of 5.45 nM to 54.5 microM. EGCG is
effective at inhibiting AP-1 activity when applied before, after or both
before and after UVB irradiation. EGCG also inhibits AP-1 activity in the
epidermis of a transgenic mouse model. This work begins to define a
mechanism by which EGCG could be acting to inhibit UVB-induced tumor
formation.
相似文献